Changes in IL-10 and specific antibodies associated to successful Dermatophagoides pteronyssinus immunotherapy in children during the first year of treatment

Allergol Immunopathol (Madr). 2013 Jan-Feb;41(1):1-3. doi: 10.1016/j.aller.2012.12.001. Epub 2013 Jan 10.

Author

Manuel Boquete-París¹

Affiliation

¹ Sección de Alergologia, Hospital Lucus Augusti, Lugo, Spain.

PMID: 23313160
DOI: 10.1016/j.aller.2012.12.001

No abstract available

Publication types

Editorial

MeSH terms

Animals
Antibodies / blood*
Antigens, Dermatophagoides / therapeutic use*
Child
Cholecalciferol / therapeutic use
Combined Modality Therapy
Dermatophagoides pteronyssinus / immunology*
Desensitization, Immunologic / methods*
Humans
Hypersensitivity / immunology
Hypersensitivity / therapy*
Interleukin-10 / immunology*
T-Lymphocytes, Regulatory / immunology
Treatment Outcome

Substances

Antibodies
Antigens, Dermatophagoides
IL10 protein, human
Interleukin-10
Cholecalciferol